Kooth (KOO) Competitors GBX 162 -7.00 (-4.14%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlines KOO vs. INS, RENX, COG, INHC, FDBK, IQAI, DVRG, TRLS, SENS, and EMISShould you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry. Kooth vs. Instem Renalytix Cambridge Cognition Induction Healthcare Group Feedback IQ-AI DeepVerge Trellus Health Sensyne Health EMIS Group Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment. Do analysts rate KOO or INS? Kooth currently has a consensus price target of GBX 585, indicating a potential upside of 261.11%. Given Kooth's stronger consensus rating and higher probable upside, equities analysts clearly believe Kooth is more favorable than Instem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kooth 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Instem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer KOO or INS? Instem received 83 more outperform votes than Kooth when rated by MarketBeat users. However, 90.91% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote. CompanyUnderperformOutperformKoothOutperform Votes1090.91% Underperform Votes19.09%InstemOutperform Votes9352.25% Underperform Votes8547.75% Which has higher earnings and valuation, KOO or INS? Kooth has higher earnings, but lower revenue than Instem. Kooth is trading at a lower price-to-earnings ratio than Instem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKooth£54.17M1.09£4.28M£0.121,350.00Instem£61.63M3.24£3.34M£0.145,928.57 Which has more risk and volatility, KOO or INS? Kooth has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Is KOO or INS more profitable? Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 23.83% beat Instem's return on equity.Company Net Margins Return on Equity Return on Assets Kooth7.89% 23.83% 10.12% Instem 5.50%6.35%4.62% Do institutionals and insiders hold more shares of KOO or INS? 65.0% of Kooth shares are held by institutional investors. Comparatively, 65.9% of Instem shares are held by institutional investors. 17.3% of Kooth shares are held by insiders. Comparatively, 30.0% of Instem shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media refer more to KOO or INS? In the previous week, Kooth's average media sentiment score of 0.00 equaled Instem'saverage media sentiment score. Company Overall Sentiment Kooth Neutral Instem Neutral SummaryKooth beats Instem on 9 of the 16 factors compared between the two stocks. Ad DTIDo this if you missed cheap BitcoinDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Because a new blockchain is taking the world by storm… It’s seeing rapid adoption amongst crypto fans… And just now starting to break into the mainstream. While I cannot promise future returns or against losses… This might not just be another chance at Bitcoin-like gains… It could be EVEN bigger. But this market is moving fast… So if you want a shot at getting in on what could be the ground floorClick Here for Details. Get Kooth News Delivered to You Automatically Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOO vs. The Competition Export to ExcelMetricKoothHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£59.10M£160.58M£5.16B£1.65BDividend YieldN/A6.94%5.18%6.87%P/E Ratio1,350.00599.4068.561,784.26Price / Sales1.09286.531,271.87253,178.35Price / Cash5.4242.4339.7127.62Price / Book2.354.326.482.85Net Income£4.28M-£7.04M£119.82M£159.30M7 Day Performance-4.71%0.04%-5.13%-0.63%1 Month Performance-42.37%2.59%-2.71%3.41%1 Year Performance-45.64%-0.48%31.10%126.74% Kooth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KOOKoothN/AGBX 162-4.1%GBX 585+261.1%-46.0%£59.10M£54.17M1,350.00478INSInstemN/AN/AN/A+0.0%£199.62M£61.63M5,928.57500RENXRenalytixN/AGBX 7.50-6.3%N/A-68.6%£12.45M£2.29M-31.25102COGCambridge CognitionN/AGBX 29+1.8%N/A-48.2%£12.16M£13.08M-725.0080Gap DownINHCInduction Healthcare GroupN/AGBX 8.95-8.2%N/A-63.4%£8.40M£13.65M-298.3374Gap DownHigh Trading VolumeFDBKFeedbackN/AGBX 20.35-0.7%N/A-74.4%£2.71M£1.18M-81.4024High Trading VolumeIQAIIQ-AIN/AGBX 1.02-7.7%N/A-72.5%£2.25M£538,190.00-13.676DVRGDeepVergeN/AGBX 0.15flatN/AN/A£1.14M£12.41M-15.0073TRLSTrellus HealthN/AGBX 0.65-3.7%N/A-85.8%£1.05M£35,000.00-21.6731Gap DownSENSSensyne HealthN/AGBX 0.35-33.3%N/AN/A£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AGBX 1,920flatN/AN/A£1.23B£176.86M4,085.111,560 Related Companies and Tools Related Companies INS Competitors RENX Competitors COG Competitors INHC Competitors FDBK Competitors IQAI Competitors DVRG Competitors TRLS Competitors SENS Competitors EMIS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:KOO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kooth plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kooth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.